Healthcare provider profile · identity verified

James Arthur Gibson, M.D.

Internal Medicine · WATERFORD, MI · NPI 1104838655

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	806	225
Amlodipine Besylate	Amlodipine Besylate	632	170
Prednisone	Prednisone	620	309
Levothyroxine Sodium	Levothyroxine Sodium	554	146
Losartan Potassium	Losartan Potassium	438	115
Omeprazole	Omeprazole	380	113
Metformin Hcl	Metformin Hcl	323	87
Metoprolol Succinate	Metoprolol Succinate	318	92
Lisinopril	Lisinopril	294	81
Alprazolam	Alprazolam	279	59
Tramadol Hcl	Tramadol Hcl	257	72
Glimepiride	Glimepiride	246	70
Eliquis	Apixaban	241	54
Simvastatin	Simvastatin	225	53
Sertraline Hcl	Sertraline Hcl	215	59
Tamsulosin Hcl	Tamsulosin Hcl	213	59
Gabapentin	Gabapentin	189	44
Meloxicam	Meloxicam	162	54
Pantoprazole Sodium	Pantoprazole Sodium	161	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	155	26
Potassium Chloride	Potassium Chloride	155	41
Diclofenac Sodium	Diclofenac Sodium	142	52
Furosemide	Furosemide	142	42
Famotidine	Famotidine	141	42
Albuterol Sulfate Hfa	Albuterol Sulfate	133	64
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	132	41
Pravastatin Sodium	Pravastatin Sodium	130	35
Rosuvastatin Calcium	Rosuvastatin Calcium	125	41
Zolpidem Tartrate	Zolpidem Tartrate	118	17
Allopurinol	Allopurinol	110	27
Buspirone Hcl	Buspirone Hcl	108	26
Quetiapine Fumarate	Quetiapine Fumarate	106	33
Trazodone Hcl	Trazodone Hcl	102	22
Hydrochlorothiazide	Hydrochlorothiazide	100	33
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	99	25
Metoprolol Tartrate	Metoprolol Tartrate	97	27
Montelukast Sodium	Montelukast Sodium	95	27
Mounjaro	Tirzepatide	94	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	92	21
Cefuroxime	Cefuroxime Axetil	90	72
Mirtazapine	Mirtazapine	88	23
Azithromycin	Azithromycin	87	78
Doxycycline Hyclate	Doxycycline Hyclate	86	70
Ipratropium Bromide	Ipratropium Bromide	86	36
Clopidogrel	Clopidogrel Bisulfate	83	26
Triamcinolone Acetonide	Triamcinolone Acetonide	77	60
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	22
Donepezil Hcl	Donepezil Hcl	75	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	24
Bumetanide	Bumetanide	71	23
Xarelto	Rivaroxaban	70	15
Atenolol	Atenolol	69	18
Hydralazine Hcl	Hydralazine Hcl	69	21
Duloxetine Hcl	Duloxetine Hcl	67	18
Finasteride	Finasteride	66	22
Escitalopram Oxalate	Escitalopram Oxalate	62	15
Irbesartan	Irbesartan	61	19
Spironolactone	Spironolactone	60	16
Ozempic	Semaglutide	59	16
Carvedilol	Carvedilol	58	18
Pioglitazone Hcl	Pioglitazone Hcl	58	18
Bupropion Xl	Bupropion Hcl	54	19
Jardiance	Empagliflozin	54	15
Metformin Hcl Er	Metformin Hcl	50	13
Tizanidine Hcl	Tizanidine Hcl	50	31
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	49	25
Valacyclovir	Valacyclovir Hcl	48	17
Fluticasone Propionate	Fluticasone Propionate	47	17
Ezetimibe	Ezetimibe	46	13
Ibuprofen	Ibuprofen	44	14
Warfarin Sodium	Warfarin Sodium	44	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	38
Nifedipine Er	Nifedipine	41	12
Oxybutynin Chloride	Oxybutynin Chloride	41	16
Fluoxetine Hcl	Fluoxetine Hcl	40	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	12
Fenofibrate	Fenofibrate	37	suppressed
Amoxicillin	Amoxicillin	36	31
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	26
Hydroxyzine Hcl	Hydroxyzine Hcl	35	14
Levofloxacin	Levofloxacin	35	21
Paxlovid	Nirmatrelvir/Ritonavir	35	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	13
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Estradiol	Estradiol	32	14
Hydrocortisone	Hydrocortisone	32	suppressed
Januvia	Sitagliptin Phosphate	32	13
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	26
Metronidazole	Metronidazole	30	26
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	13
Memantine Hcl	Memantine Hcl	28	suppressed
Nystatin	Nystatin	28	15
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Azelastine Hcl	Azelastine Hcl	27	11
Celecoxib	Celecoxib	27	11
Fluconazole	Fluconazole	27	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	19
Trulicity	Dulaglutide	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Ondansetron Odt	Ondansetron	26	22
Clonazepam	Clonazepam	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Cephalexin	Cephalexin	23	18
Farxiga	Dapagliflozin Propanediol	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	11
Divalproex Sodium	Divalproex Sodium	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Lactulose	Lactulose	20	suppressed
Naproxen	Naproxen	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	13
Alendronate Sodium	Alendronate Sodium	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Fluocinonide	Fluocinonide	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Cilostazol	Cilostazol	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	14
Entresto	Sacubitril/Valsartan	18	suppressed
Flecainide Acetate	Flecainide Acetate	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Meclizine Hcl	Meclizine Hcl	15	12
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Invokana	Canagliflozin	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Temazepam	Temazepam	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Indapamide	Indapamide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Metolazone	Metolazone	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Lamotrigine Er	Lamotrigine	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Vemlidy	Tenofovir Alafenamide	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Atovaquone	Atovaquone	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error